Instil Bio Inc (TIL)
25.91
+1.15
(+4.64%)
USD |
NASDAQ |
Nov 22, 16:00
25.91
0.00 (0.00%)
After-Hours: 18:42
Instil Bio Total Assets (Quarterly): 272.56M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 272.56M |
| June 30, 2024 | 294.32M |
| March 31, 2024 | 306.30M |
| December 31, 2023 | 325.63M |
| September 30, 2023 | 340.27M |
| June 30, 2023 | 408.31M |
| March 31, 2023 | 427.17M |
| December 31, 2022 | 482.13M |
| Date | Value |
|---|---|
| September 30, 2022 | 532.74M |
| June 30, 2022 | 568.54M |
| March 31, 2022 | 564.94M |
| December 31, 2021 | 609.98M |
| September 30, 2021 | 647.40M |
| June 30, 2021 | 672.67M |
| March 31, 2021 | 696.14M |
| December 31, 2020 | 319.01M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
272.56M
Minimum
Sep 2024
696.14M
Maximum
Mar 2021
466.76M
Average
454.65M
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co Inc | 117.53B |
| Elite Pharmaceuticals Inc | 88.20M |
| BioCardia Inc | 6.267M |
| Zevra Therapeutics Inc | 191.55M |
| NovaBay Pharmaceuticals Inc | 3.877M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 96.23M |
| Shareholders Equity (Quarterly) | 176.33M |